Victory Capital Management’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.4K Sell
18,792
-965
-5% -$1.88K ﹤0.01% 2482
2026
Q2
$41.3K Buy
19,757
+3,303
+20% +$6.5K ﹤0.01% 2405
2026
Q1
$28.8K Buy
16,454
+382
+2% +$695 ﹤0.01% 2358
2025
Q4
$37.8K Buy
+16,072
New +$30.9K ﹤0.01% 2353
2020
Q2
– Hold
0
– -$1K – 3043
2020
Q1
– Hold
0
– – – 3630
2019
Q4
– Hold
0
– – – 3073
2019
Q3
– Hold
0
– – – 3779

Other funds holding PALI

Victory Capital Management's PALI Position: Q3 2026 in Review

Victory Capital Management reduced its Palisade Bio (PALI) stake by 4.9% in Q3 2026, selling an estimated $1.88K and leaving 18,792 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2482.

Victory Capital Management first reported a position in PALI in Q4 2025 and has held it in 4 quarters since. The position peaked at $41.3K in Q2 2026. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Victory Capital Management held 18,792 shares of Palisade Bio worth $25.4K as of Q3 2026.
  • Victory Capital Management sold 965 Palisade Bio shares in Q3 2026, an estimated $1.88K.
  • Palisade Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2482 holding.
  • Victory Capital Management first reported a position in Palisade Bio in Q4 2025 and has held it in 4 quarters since.
  • Victory Capital Management's Palisade Bio position peaked at $41.3K in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.